Modeled Hepatic/Plasma Exposures of Omeprazole Prescribed Alone in Cytochrome P450 2C19 Poor Metabolizers Are Likely Associated with Hepatic Toxicity Reported in a Japanese Adverse Event Database-Reference-Cited by-同舟云学术

Modeled Hepatic/Plasma Exposures of Omeprazole Prescribed Alone in Cytochrome P450 2C19 Poor Metabolizers Are Likely Associated with Hepatic Toxicity Reported in a Japanese Adverse Event Database

Published:2024-05-24 Issue:5 Volume:47 Page:1028-1032
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biological & Pharmaceutical Bulletin

Author:

Adachi Koichiro¹,Ohyama Katsuhiro²,Tanaka Yoichi³,Murayama Norie¹,Shimizu Makiko¹,Saito Yoshiro³,Yamazaki Hiroshi¹

Affiliation:

1. Showa Pharmaceutical University

2. School of Pharmacy, Tokyo University of Pharmacy and Life Sciences

3. National Institute of Health Sciences

Publisher

Pharmaceutical Society of Japan

Link

https://www.jstage.jst.go.jp/article/bpb/47/5/47_b24-00145/_pdf

Reference22 articles.

1. 1) Tsuchiya M, Obara T, Sakai T, Nomura K, Takamura C, Mano N. Quality evaluation of the Japanese Adverse Drug Event Report database (JADER). Pharmacoepidemiol. Drug Saf., 29, 173–181 (2020).

2. 2) Ohyama K, Hirakawa K, Sasazaki K, Tanaka H, Hori Y, Takeuchi H. Time-to-onset of diabetes with everolimus use: analysis of a spontaneous reporting system database. Pharmazie, 76, 515–518 (2021).

3. 3) Ohyama K, Tanaka H, Hori Y. Effect of concomitant drug use on the onset and exacerbation of diabetes mellitus in everolimus-treated cancer. J. Pharm. Pharm. Sci., 25, 245–252 (2022).

4. 4) Ohyama K, Akiyama S, Iida M, Hori Y. Association of torsade de pointes and QT prolongation with antifungal triazoles: analysis using a pharmacovigilance database. In Vivo, 37, 2719–2725 (2023).

5. 5) Furuta T, Shirai N, Sugimoto M, Ohashi K, Ishizaki T. Pharmacogenomics of proton pump inhibitors. Pharmacogenomics, 5, 181–202 (2004).